0001104659-24-065121.txt : 20240524
0001104659-24-065121.hdr.sgml : 20240524
20240524160528
ACCESSION NUMBER: 0001104659-24-065121
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240516
FILED AS OF DATE: 20240524
DATE AS OF CHANGE: 20240524
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Fortress Biotech, Inc.
CENTRAL INDEX KEY: 0001429260
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38128
FILM NUMBER: 24984245
BUSINESS ADDRESS:
STREET 1: 1111 KANE CONCOURSE
STREET 2: SUITE 301
CITY: BAY HARBOR ISLANDS
STATE: FL
ZIP: 33154
BUSINESS PHONE: 781-652-4500
MAIL ADDRESS:
STREET 1: 1111 KANE CONCOURSE
STREET 2: SUITE 301
CITY: BAY HARBOR ISLANDS
STATE: FL
ZIP: 33154
FORMER NAME:
FORMER CONFORMED NAME: CORONADO BIOSCIENCES INC
DATE OF NAME CHANGE: 20080310
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Checkpoint Therapeutics, Inc.
CENTRAL INDEX KEY: 0001651407
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 472568632
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 95 SAWYER ROAD
STREET 2: SUITE 110
CITY: WALTHAM
STATE: MA
ZIP: 02453
BUSINESS PHONE: 781-652-4500
MAIL ADDRESS:
STREET 1: 95 SAWYER ROAD
STREET 2: SUITE 110
CITY: WALTHAM
STATE: MA
ZIP: 02453
3
1
tm2415586-1_3seq1.xml
OWNERSHIP DOCUMENT
X0206
3
2024-05-16
0
0001651407
Checkpoint Therapeutics, Inc.
CKPT
0001429260
Fortress Biotech, Inc.
1111 KANE CONCOURSE, SUITE 301
BAY HARBOR ISLANDS
FL
33154
0
0
1
0
COMMON STOCK, PAR VALUE $0.0001
3589193
D
CLASS A COMMON STOCK, PAR VALUE $0.0001
Common Stock
700000
D
Each share of the Issuer's Class A Common Stock is convertible at any time at the option of the Reporting Person into one share of the Issuer's Common Stock and has no expiration date.
/s/ Lindsay A. Rosenwald, M.D. Chairman, President and Chief Executive Officer
2024-05-24